Oral vaccines against cholera: Lessons from Vietnam and elsewhere

Lancet

Volumn 349, Issue 9047, 1997, Pages 220-221

  Levine, M M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; HEMAGGLUTININ; INACTIVATED VACCINE;

ADOLESCENT; ADULT; BANGLADESH; CHILD; CHOLERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; FEMALE; FIMBRIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHORT SURVEY; VIET NAM;

EID: 0031032996     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)22004-0     Document Type: Note

References (7)

1. JD Clemens DA Sack JR Harris Field trial of oral cholera vaccines in Bangladesh Lancet ii 1986 124 127
2. JD Clemens DA Sack JR Harris Field trial of cholera vaccines in Bangladesh: results from three year follow-up Lancet 335 1990 270 273
3. MM Levine JB Kaper Live oral cholera vaccine: from principle to product Bull Inst Pasteur 93 1995 243 253
4. DA Herrington RH Hall G Losonsky JJ Mekalanos RK Taylor MM Levine Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans J Exp Med 168 1988 1487 1492
5. RH Hall G Losonsky AP Silvera Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera Infect Immun 59 1991 2508 2512
6. A Batson P Evans JB Milstien The crisis in vaccine supply: a framework for action Vaccine 12 1994 963 965
7. CO Tacket G Losonsky JP Nataro Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR J Infect Dis 166 1992 837 841